Physician profile
Edward J Mcpherson
NPI 1659360576
$1,213,285.68
in general payments reported to CMS, 2019-2025
9 companies · $194K in 2025
The $194K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382K · 2020: $289K · 2021: $47K · 2022: $13K · 2023: $121K · 2024: $166K · 2025: $194K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $301K · Consulting Fee: $78K · Education: $53K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25K · Travel and Lodging: $21K · Food and Beverage: $2,912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $301,415.71 |
| Consulting Fee | $77,781.73 |
| Education | $53,457.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25,400.00 |
| Travel and Lodging | $20,689.88 |
| Food and Beverage | $2,911.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $839,373.39 | 2019-2025 | Arcos, Persona, Arcos Revision Hip Instrumentation |
| Austin Medical Ventures INC | $284,438.56 | 2019-2025 | Synthecure, Synthecure Calcium Sulfate |
| Biocomposites INC | $40,173.34 | 2019 | |
| Bone Support INC. | $25,501.39 | 2021-2025 | Ceramentbone Void Filler, Cerament G |
| Heraeus Medical, LLC. | $23,254.14 | 2025 | Synthecure |
| Si-Bone, INC. | $371.52 | 2022-2023 | |
| Smith+Nephew, INC. | $121.90 | 2019 | |
| Innovation Technologies INC | $37.40 | 2023 | Irrisept |
| Depuy Synthes Sales INC. | $14.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Mcpherson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.